Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
12826
PUT
Sutro Biopharma
STRO
$340M
| $30.5K | ﹤0.01% |
1,660
+550
| +50% | +$16.8K |
|
12827
PUT
iShares MSCI Brazil Small-Cap ETF
EWZS
$205M
| $30.5K | ﹤0.01% |
3,300
+1,400
| +74% | +$15.8K |
|
12828
PUT
Schwab US Mid-Cap ETF
SCHM
$15.4B
| $30.5K | ﹤0.01% |
1,100
-2,200
| -67% | -$62.7K |
|
|
NOAH
12829
PUT
Noah Holdings
NOAH
$592M
| $30.4K | ﹤0.01% |
2,600
-8,000
| -75% | -$99K |
|
12830
Farmmi Inc
FAMI
$4.79M
| $30.4K | ﹤0.01% |
+8,432
| New | +$30.2K |
|
|
FIRY
12831
CALL
Firy Inc
FIRY
$156M
| $30.3K | ﹤0.01% |
6,025
-5,900
| -49% | -$31.5K |
|
12832
PUT
Conduent
CNDT
$236M
| $30.3K | ﹤0.01% |
7,500
-1,300
| -15% | -$5.17K |
|
12833
EpicQuest Education Group
EEIQ
$3.8M
| $30.2K | ﹤0.01% |
+1,889
| New | +$27.3K |
|
12834
PUT
Lands' End
LE
$384M
| $30.2K | ﹤0.01% |
2,300
-3,800
| -62% | -$59.6K |
|
12835
CALL
National Bank Holdings
NBHC
$1.94B
| $30.1K | ﹤0.01% |
+700
| New | +$31.7K |
|
12836
CALL
Playboy Inc
PLBY
$151M
| $30.1K | ﹤0.01% |
20,600
+15,300
| +289% | +$17.7K |
|
|
AIFF
12837
Firefly Neuroscience
AIFF
$17.1M
| $30K | ﹤0.01% |
+11,334
| New | +$35.1K |
|
12838
Grove Collaborative
GROV
$44M
| $30K | ﹤0.01% |
21,594
+2,708
| +14% | +$3.73K |
|
|
CMRC
12839
PUT
Commerce.com Inc Series 1
CMRC
$181M
| $30K | ﹤0.01% |
4,900
+2,000
| +69% | +$12.5K |
|
12840
PUT
Escalade
ESCA
$276M
| $30K | ﹤0.01% |
2,100
+300
| +17% | +$4.33K |
|
12841
PUT
Compañía de Minas Buenaventura
BVN
$8.57B
| $30K | ﹤0.01% |
2,600
+200
| +8% | +$2.56K |
|
|
VXRT
12842
PUT
DELISTED
Vaxart
VXRT
| $29.9K | ﹤0.01% |
45,200
-40,100
| -47% | -$27.9K |
|
12843
CALL
T-Rex 2X Inverse NVIDIA Daily Target ETF
NVDQ
$13.6M
| $29.9K | ﹤0.01% |
450
-1,409
| -76% | -$97.8K |
|
|
VBTX
12844
CALL
DELISTED
Veritex Holdings
VBTX
| $29.9K | ﹤0.01% |
1,100
-4,000
| -78% | -$113K |
|
12845
PUT
SELLAS Life Sciences
SLS
$2.58B
| $29.8K | ﹤0.01% |
28,700
-46,000
| -62% | -$52.5K |
|
|
NCNA
12846
NuCana
NCNA
$6.62M
| $29.8K | ﹤0.01% |
+125
| New | +$38.8K |
|
12847
Evogene
EVGN
$9.49M
| $29.7K | ﹤0.01% |
+15,891
| New | +$31.3K |
|
12848
CALL
Materion
MTRN
$5.9B
| $29.7K | ﹤0.01% |
300
-11,600
| -97% | -$1.26M |
|
12849
CALL
Woodside Energy
WDS
$44B
| $29.6K | ﹤0.01% |
1,900
-1,700
| -47% | -$27.3K |
|
12850
CALL
Anika Therapeutics
ANIK
$288M
| $29.6K | ﹤0.01% |
1,800
+1,600
| +800% | +$31.6K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.